Navigation Links
Identafi(TM) 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009
Date:7/1/2009

HOUSTON, July 1 /PRNewswire/ -- Trimira LLC's Identafi(TM) 3000 oral cancer detection device has been picked by leading dental industry magazine Dentistry Today as one of its Top 100 Products. The full results of the 23rd annual competition will be published in the July issue.

Dentistry Today noted that The Top 100 Products are selected based on reader response and represent what's new and innovative in the dental profession. Identafi(TM) 3000 is the most powerful and accurate device for screening dental patients to reveal signs of oral cancer and pre-cancer. The device incorporates next-generation oral cancer-detection "multispectral" technology that is changing the screening and diagnostic landscape for dentists and doctors across the nation.

Identafi(TM) 3000's multispectral (triple-wavelength) optical technology was developed by a team of research scientists at America's top-rated and largest cancer center, the University of Texas M.D. Anderson Cancer Center in Houston, in collaboration with Houston's Rice University and British Columbia Cancer Research Centre in Vancouver, Canada.

Identafi 3000 represents a quantum leap in the visualization of mucosal abnormalities, including oral cancer or premalignant dysplasia. The technology not only is effective in screening and diagnosing oral cancers but also has application in diagnosing cervical, gastrointestinal, skin, and bladder cancers. Unlike other methods, Identafi 3000 empowers doctors and dentists to pinpoint biochemical and morphological changes in cells.

Identafi(TM) 3000 is made by Houston-based Trimira LLC, which is venture capital-funded by cancer research philanthropist T. Boone Pickens of oil and windfarming fame.

About TRIMIRA(TM) LLC

TRIMIRA(TM) LLC is a subsidiary of Remicalm LLC, a privately held medical device and optical imaging company. Other subsidiaries are working on screening and diagnostic devices for skin, cervical, gastrointestinal, and bladder cancers. Remicalm, as the parent company, has licensed exclusive use of certain of its patents and patents pending for use as a cervical cancer product to be later expanded to include additional epithelial-based cancers. Remicalm's core technologies are based on high-speed, high-resolution capabilities from its patented optical processing technology platforms and include the ability to read metabolic and physiologic differences in diseased and healthy tissue in the human body.

Visit TRIMIRA(TM) at: http://www.trimira.net/


'/>"/>
SOURCE TRIMIRA(TM) LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Identafi(TM) 3000 Identifies Signs of Silent Killer:
2. Hospital Chain and Hand Picked Union, SEIU, Forced to Cancel Rigged Election After Protests by RNs and Other Employees
3. RNs Denounce Sham Election in Nine Ohio Hospitals, Hospital Chain Seeks to Impose Hand-Picked Union
4. American Dental Association, The Forsyth Institute Collaborate to Pilot Evidence-Based Dentistry Training Course
5. American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines
6. New ... Provisional Restorations In Dentistry DVD by Paul R. Chalifoux, DDS
7. National Museum of Dentistry Opens New Smile Experience, Exhibition Recognizes Dr. Irwin Smigel as Father of Aesthetic Dentistry
8. Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry
9. Dentistry and Mass Disasters: A Dentists Role as a First Responder During a Public Health Emergency
10. Davis Vision, Visionworks, United Concordia Dental and Louisiana State University School of Dentistry Partner with Hands on New Orleans
11. Milestone Scientific to Exhibit at the CDA Art and Science of Dentistry Spring Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Bell Agency, a full service insurance ... their ongoing community enrichment program. The current campaign fundraises for Angels & Doves, ... being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded in ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... that co-occur frequently. While a significant number of women and men with eating ... the trauma itself, that best predicts the development of an eating disorder. ...
(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... ... prolapse with the latest techniques and the most minimally invasive approaches. , Women ... prolapse, particularly after menopause. Other risk factors include surgery to the pelvic floor, ...
(Date:2/6/2016)... , ... February 06, 2016 , ... US Sports Camps ... Conference (YUCC) . This event brings together top non-profit leaders, ultimate organizations, and coaches ... Girls Ultimateā€. Valerio Iani, Bay Area Disc Program Director of Youth and Education, describes ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  Neurocrine Biosciences, Inc. (Nasdaq: ... its fourth quarter and year-end 2015 results after the ... will then host a live conference call and webcast ... update Thursday afternoon, February 11, 2016 at 4:30 p.m. ... . --> http://www.neurocrine.com . --> ...
(Date:2/8/2016)... LAWRENCEVILLE, N.J. , Feb. 8, 2016   ... for healthcare professionals to guide them through GS1 Standards ... and Drug Administration (FDA) Unique Device Identification (UDI) rule. ... standards, GS1 US; Beth Gibson , senior director ... Roberts , industry development director, GS1 US ...
(Date:2/8/2016)... 8, 2016   HighPoint Solutions today ... (NRG),s pharmacovigilance technology services division.  NRG is a ... an Oracle Argus Specialized partner, providing drug safety ... companies. --> --> ... sciences capabilities and provides a global scale and ...
Breaking Medicine Technology: